Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2024
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service,
· University of Rochester,
· University of Cincinnati,
· Cincinnati Children's Hospital Medical Center,
· Vanderbilt University,
· Texas Children's Hospital,
· Baylor College of Medicine,
· University of Washington,
· University of Pittsburgh,
· Children's Mercy Kansas City
This study looks at the impact of respiratory syncytial virus (RSV) in young children during the 2023-2024 season. It describes how two new RSV prevention …
Ask aRCie
Monoclonal Antibodies for Prophylaxis and Treatment of Respiratory Viral Infections
This article discusses the use of monoclonal antibodies (mAbs) to prevent and treat respiratory viral infections, especially in people with weak immune systems. It describes …
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
2023
· University of Washington,
· State University of New York - Upstate Medical University,
· Seattle Children's Hospital
This article provides an update on respiratory syncytial virus (RSV) for prenatal and primary health providers. It emphasizes the lack of data on RSV infection …